Clinitech Laboratory Ltd
company logo

Clinitech Laboratory Ltd

CTLLAB Share Price

BSE:544220

45.5

1.90 (4.36%)

As on April 17, 2026 at 04:00 PM
Loading chart...

Performance

Loading performance...

43.60

45.84

3600

0.02

10

Fundamentals

10.38Cr

29.93

1.18

0.07

1.52

0%

38.69

About

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai. The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai. Company is in the business of healthcare services providing superior quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc. The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018. Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests. Clinical pathology is a medical specialty that focuses on the diagnosis of diseases and conditions through the analysis of bodily fluids and tissues. It includes various laboratory tests and techniques such as blood tests, urine analysis, and tissue biopsies to help healthcare professionals understand the underlying causes of a patient's symptoms and guide treatment decisions. Clinical pathologists play a crucial role in interpreting test results and providing valuable information to aid in patient care. Imaging diagnosis or radiology involves imaging procedures such as X-rays and ultrasounds that help determine anatomical or physiological changes inside a patient's body, thus assisting doctors in diagnosing. It includes more complex tests such as CT scans, MRIs, and highly specialized PET-CT scans. The Company issued and allotted 6,02,400 equity shares of Rs 10 each and raised funds, comprising a fresh issue of Rs 5.78 crores on 29 July, 2024.

Jagdish Umakant Nayak

2010

NameDesignation
Jagdish Umakant NayakChairman & Managing Director
Jyoti Jagdish NayakWhole-time Director
Ashutosh Jagdish NayakNon-Exec & Non-Independent Dir
Balu Laxman KumbharkarIndependent Non Exe. Director
Smita Arjun PatilIndependent Non Exe. Director
Ravikant Moreshwar MhatreIndependent Non Exe. Director
Shruti Hemant PatankarCompany Sec. & Compli. Officer

Clinitech Laboratory Ltd FAQs

How do I Buy Clinitech Laboratory Ltd Shares?

close

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Clinitech Laboratory Ltd shares in BlinkX.

What is the Share Price of Clinitech Laboratory Ltd?

close

The share price of any stock is volatile and changes during the day due to a variety of variables. Clinitech Laboratory Ltd's share price is ₹45.5 as of 2026-04-19.

What is the PE ratio of Clinitech Laboratory Ltd?

close

Clinitech Laboratory Ltd's P/E ratio is 29.93 times as of 2026-04-19.

What is the PB ratio of Clinitech Laboratory Ltd?

close

Clinitech Laboratory Ltd's most recent financial reports indicate a price-to-book ratio of 1.18, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Clinitech Laboratory Ltd?

close

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Clinitech Laboratory Ltd's market capitalization is ₹10.38 Cr as on 2026-04-19.

What is the ROE of Clinitech Laboratory Ltd?

close

The current financial records of Clinitech Laboratory Ltd show a 5.49% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Clinitech Laboratory Ltd?

close

According to Clinitech Laboratory Ltd's most recent financial filings, the company has a total asset value of ₹7.51, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Clinitech Laboratory Ltd?

close

The 52-week high/low price of a Clinitech Laboratory Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Clinitech Laboratory Ltd's 52-week high and low as of 2026-04-19 are ₹57 and ₹28.55, respectively.